Unknown

Dataset Information

0

Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands.

ABSTRACT: Antinociceptive ligand HZ-166 is a GABAA α2/α3 receptor subtype-selective potentiator. It has been shown to exhibit anxiolytic-like effects in rodent and rhesus monkeys, as well as reduced sedative/ataxic liabilities. In order to improve the metabolic stability of HZ-166, the ethyl ester moiety was bioisosterically replaced with 2,4-disubstituted oxazoles and oxazolines. The new analogs of HZ-166 were synthesized, characterized, and evalutated for their biological activity and docked in the human full-length heteromeric α1β3γ2L GABAA receptor subtype CyroEM structure (6HUO). Importantly no sedation nor ataxia was observed on the rotorod for LKG-I-70 (6) or KPP-III-51 (6c) at 100 and 120 mg/kg, respectively. These was also no loss of righting response for either ligand.

SUBMITTER: Pandey KP 

PROVIDER: S-EPMC7909486 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antinociceptive ligand HZ-166 is a GABA<sub>A</sub> α2/α3 receptor subtype-selective potentiator. It has been shown to exhibit anxiolytic-like effects in rodent and rhesus monkeys, as well as reduced sedative/ataxic liabilities. In order to improve the metabolic stability of HZ-166, the ethyl ester moiety was bioisosterically replaced with 2,4-disubstituted oxazoles and oxazolines. The new analogs of HZ-166 were synthesized, characterized, and evalutated for their biological activity and docked  ...[more]

Similar Datasets

Unknown theta, a novel gamma-aminobutyric acid type A receptor subunit.
| S-EPMC22306 | biostudies-literature
Unknown Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.
| S-EPMC6941172 | biostudies-literature
Unknown A Novel Bifunctional Alkylphenol Anesthetic Allows Characterization of γ-Aminobutyric Acid, Type A (GABAA), Receptor Subunit Binding Selectivity in Synaptosomes.
| S-EPMC5034043 | biostudies-literature
Unknown γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
| S-EPMC3307276 | biostudies-literature
Unknown Altered gamma-aminobutyric acid type B receptor subunit 1 splicing in alcoholics.
| S-EPMC3999301 | biostudies-literature
Unknown Proteomic Characterization of Inhibitory Synapses Using a Novel pHluorin-tagged γ-Aminobutyric Acid Receptor, Type A (GABAA), α2 Subunit Knock-in Mouse.
| S-EPMC4933285 | biostudies-literature
Unknown The third gamma subunit of the gamma-aminobutyric acid type A receptor family.
| S-EPMC48465 | biostudies-other
Unknown Synthesis and Characterization of a Novel ?-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy.
| S-EPMC5215686 | biostudies-literature
Unknown Dendritic assembly of heteromeric gamma-aminobutyric acid type B receptor subunits in hippocampal neurons.
| S-EPMC2676040 | biostudies-literature
Unknown Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
| S-EPMC5014730 | biostudies-literature